TAYLOR HENDON: Open Payments
NPI 1588019772 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$813 in 35 payments from 16 companies in 2025. Trend: 2023 $3,048 · 2024 $3,172 · 2025 $813
Food & beverage: $813
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $122 |
| Lilly USA, LLC | 4 | $86 |
| Abbott Laboratories | 3 | $79 |
| Insulet Corporation | 3 | $68 |
| BETA BIONICS, INC. | 3 | $65 |
| Mannkind Corporation | 3 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Tandem Diabetes Care, Inc. | 2 | $47 |
| Medtronic, Inc. | 2 | $37 |
Products named: MOUNJARO, Ozempic, FREESTYLE LIBRE 3, Omnipod, iLet Bionic Pancreas, AFREZZA, JARDIANCE, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
